Browsing Tag
NSE
128 posts
How to read Indian company earnings reports: A complete beginner’s guide (2025 edition)
Learn how to read Indian company earnings reports like a pro. Understand EPS, EBITDA, and more in this complete beginner’s guide for 2025.
Nucleus Software surges 20% on strong FY25 results, AI-driven vision, and midcap IT optimism
Nucleus Software stock surged 20% after FY25 results and AI-first strategy reveal. Find out why investors are bullish on this rising midcap IT player.
IRIS Business Services posts 51% YoY profit surge in FY25 on SupTech-led growth
IRIS Business Services posts 51% YoY profit jump in FY25 with strong SupTech and RegTech momentum—see what’s powering its global RegTech expansion.
Dollar Industries smashes revenue records in FY25 as e-commerce sales surge over 60%
Dollar Industries posts record FY25 revenue of ₹1,716 crore as digital and modern trade channels drive growth. Find out how the company is transforming today.
Alicon Castalloy delivers strong sequential Q4 FY25 gains, but faces annual profit slide amid margin pressure
Alicon Castalloy sees Q4 FY25 profit jump over 1,100% QoQ, but FY25 net profit dips 25% YoY. Find out what’s driving the company’s mixed performance.
Ventive Hospitality FY25 profit crosses Rs 1,000cr mark amid record occupancy and TRevPAR surge
Luxury hotel operator Ventive Hospitality Ltd has announced a milestone full-year performance for FY 2025, with EBITDA breaching ₹1,000 crore and revenue crossing ₹2,160 crore, making it one of India’s top four most profitable listed hospitality firms.
Asahi Songwon Colors Q4 FY25 net profit surges 658% YoY as pigment demand rebounds
Asahi Songwon's net profit soared 658% in Q4 FY25 amid pigment demand growth and debt reduction. Read the full report with sentiment and stock analysis.
India Shelter Finance Q4 FY25 profit jumps 39%, AUM crosses Rs 8,189cr on Tier-II housing loan demand
India Shelter Finance reports 39% YoY jump in Q4 FY25 profit, driven by 35% AUM growth and rising affordable housing demand. Read the full earnings update.
Max India RE surges 27% as rights issue gains investor attention post listing
Max India's RE surged 27% post-listing as investors chase rights issue gains. Learn about entitlement trading, key dates, and subscription insights.
Aarti Drugs soars with Q4 FY25 profit spike—But what’s behind the full-year revenue drop?
Aarti Drugs Q4 FY25 profit rose 33% YoY as exports rebounded, but full-year revenue declined 5%. See what’s behind the surge—and the challenges ahead.